Piramal Enterprises gains after acquiring four brands from Pfizer

Image
Capital Market
Last Updated : May 17 2016 | 12:02 AM IST

Piramal Enterprises gained 1.54% to Rs 1,283 at 11:30 IST on BSE after the company said that its consumer products division has entered into an agreement to acquire four brands from Pfizer for a consideration of Rs 110 crore.

The announcement was made after market hours on Friday, 13 May 2016.

Meanwhile, the BSE Sensex was down 113.75 points, or 0.45%, to 25,75.82.

On BSE, so far 4,275 shares were traded in the counter, compared with an average volume of 24,441 shares in the past one quarter. The stock hit a high of Rs 1,292 and a low of Rs 1,266.50 so far during the day. The stock hit a record high of Rs 1,305 on 10 May 2016. The stock hit a 52-week low of Rs 805 on 18 September 2015. The stock had outperformed the market over the past one month till 13 May 2016, gaining 16.78% compared with 0.54% decline in the Sensex. The scrip had also outperformed the market in past one quarter, rising 32.95% as against Sensex's 10.89% gains.

The large-cap company has an equity capital of Rs 34.51 crore. Face value per share is Rs 2.

Piramal Enterprises said that the acquisition includes brands namely, Ferradol, Neko, Sloan's and Waterbury's Compound. Additionally, the agreement also includes the trademark rights for Ferradol and Waterbury's Compound in Bangladesh and Sri Lanka. These brands hold a rich legacy and have a high consumer pull and are available in India for the past 30 plus years, Piramal said in a statement. These products currently operate in a market which is currently estimated at Rs 7000 crore, it added. Completion of the deal is subject to certain conditions including regulatory approvals, Piramal said.

Shares of Pfizer gained 0.71% to Rs 1,793.20.

On consolidated basis, Piramal Enterprises' net profit rose 29.2% to Rs 321.71 crore on 33.4% rise in net sales to Rs 1847.71 crore in Q3 December 2015 over Q3 December 2014.

Piramal Enterprises is one of India's large diversified companies, with a presence in healthcare, healthcare information management and financial services.

Powered by Capital Market - Live News

*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

More From This Section

First Published: May 16 2016 | 11:26 AM IST

Next Story